239 related articles for article (PubMed ID: 29358288)
1.
Suwunnakorn S; Wakabayashi H; Kordalewska M; Perlin DS; Rustchenko E
Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29358288
[No Abstract] [Full Text] [Related]
2. Fks1 and Fks2 are functionally redundant but differentially regulated in Candida glabrata: implications for echinocandin resistance.
Katiyar SK; Alastruey-Izquierdo A; Healey KR; Johnson ME; Perlin DS; Edlind TD
Antimicrob Agents Chemother; 2012 Dec; 56(12):6304-9. PubMed ID: 23027185
[TBL] [Abstract][Full Text] [Related]
3. Effect of Candida glabrata FKS1 and FKS2 mutations on echinocandin sensitivity and kinetics of 1,3-beta-D-glucan synthase: implication for the existing susceptibility breakpoint.
Garcia-Effron G; Lee S; Park S; Cleary JD; Perlin DS
Antimicrob Agents Chemother; 2009 Sep; 53(9):3690-9. PubMed ID: 19546367
[TBL] [Abstract][Full Text] [Related]
4. Clinically significant micafungin resistance in Candida albicans involves modification of a glucan synthase catalytic subunit GSC1 (FKS1) allele followed by loss of heterozygosity.
Niimi K; Monk BC; Hirai A; Hatakenaka K; Umeyama T; Lamping E; Maki K; Tanabe K; Kamimura T; Ikeda F; Uehara Y; Kano R; Hasegawa A; Cannon RD; Niimi M
J Antimicrob Chemother; 2010 May; 65(5):842-52. PubMed ID: 20233776
[TBL] [Abstract][Full Text] [Related]
5. Novel
Hou X; Healey KR; Shor E; Kordalewska M; Ortigosa CJ; Paderu P; Xiao M; Wang H; Zhao Y; Lin LY; Zhang YH; Li YZ; Xu YC; Perlin DS; Zhao Y
Emerg Microbes Infect; 2019; 8(1):1619-1625. PubMed ID: 31711370
[TBL] [Abstract][Full Text] [Related]
6. Reconstitution of high-level micafungin resistance detected in a clinical isolate of Candida glabrata identifies functional homozygosity in glucan synthase gene expression.
Niimi K; Woods MA; Maki K; Nakayama H; Hatakenaka K; Chibana H; Ikeda F; Ueno K; Niimi M; Cannon RD; Monk BC
J Antimicrob Chemother; 2012 Jul; 67(7):1666-76. PubMed ID: 22514266
[TBL] [Abstract][Full Text] [Related]
7. Positions and numbers of FKS mutations in Candida albicans selectively influence in vitro and in vivo susceptibilities to echinocandin treatment.
Lackner M; Tscherner M; Schaller M; Kuchler K; Mair C; Sartori B; Istel F; Arendrup MC; Lass-Flörl C
Antimicrob Agents Chemother; 2014 Jul; 58(7):3626-35. PubMed ID: 24733467
[TBL] [Abstract][Full Text] [Related]
8. Fitness and virulence costs of Candida albicans FKS1 hot spot mutations associated with echinocandin resistance.
Ben-Ami R; Garcia-Effron G; Lewis RE; Gamarra S; Leventakos K; Perlin DS; Kontoyiannis DP
J Infect Dis; 2011 Aug; 204(4):626-35. PubMed ID: 21791665
[TBL] [Abstract][Full Text] [Related]
9. Echinocandin resistance due to simultaneous FKS mutation and increased cell wall chitin in a Candida albicans bloodstream isolate following brief exposure to caspofungin.
Imtiaz T; Lee KK; Munro CA; MacCallum DM; Shankland GS; Johnson EM; MacGregor MS; Bal AM
J Med Microbiol; 2012 Sep; 61(Pt 9):1330-1334. PubMed ID: 22653922
[TBL] [Abstract][Full Text] [Related]
10. Effects of Echinocandins in Combination with Nikkomycin Z against Invasive Candida albicans Bloodstream Isolates and the
Cheung YY; Hui M
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28827418
[TBL] [Abstract][Full Text] [Related]
11. Role of Fks1p and matrix glucan in Candida albicans biofilm resistance to an echinocandin, pyrimidine, and polyene.
Nett JE; Crawford K; Marchillo K; Andes DR
Antimicrob Agents Chemother; 2010 Aug; 54(8):3505-8. PubMed ID: 20516280
[TBL] [Abstract][Full Text] [Related]
12. Stress-Induced Changes in the Lipid Microenvironment of β-(1,3)-d-Glucan Synthase Cause Clinically Important Echinocandin Resistance in Aspergillus fumigatus.
Satish S; Jiménez-Ortigosa C; Zhao Y; Lee MH; Dolgov E; Krüger T; Park S; Denning DW; Kniemeyer O; Brakhage AA; Perlin DS
mBio; 2019 Jun; 10(3):. PubMed ID: 31164462
[No Abstract] [Full Text] [Related]
13. Resistance to echinocandins comes at a cost: the impact of FKS1 hotspot mutations on Candida albicans fitness and virulence.
Ben-Ami R; Kontoyiannis DP
Virulence; 2012; 3(1):95-7. PubMed ID: 22286697
[TBL] [Abstract][Full Text] [Related]
14. Pyrosequencing to detect mutations in FKS1 that confer reduced echinocandin susceptibility in Candida albicans.
Wiederhold NP; Grabinski JL; Garcia-Effron G; Perlin DS; Lee SA
Antimicrob Agents Chemother; 2008 Nov; 52(11):4145-8. PubMed ID: 18794385
[TBL] [Abstract][Full Text] [Related]
15. Specific substitutions in the echinocandin target Fks1p account for reduced susceptibility of rare laboratory and clinical Candida sp. isolates.
Park S; Kelly R; Kahn JN; Robles J; Hsu MJ; Register E; Li W; Vyas V; Fan H; Abruzzo G; Flattery A; Gill C; Chrebet G; Parent SA; Kurtz M; Teppler H; Douglas CM; Perlin DS
Antimicrob Agents Chemother; 2005 Aug; 49(8):3264-73. PubMed ID: 16048935
[TBL] [Abstract][Full Text] [Related]
16. Identification of the FKS1 gene of Candida albicans as the essential target of 1,3-beta-D-glucan synthase inhibitors.
Douglas CM; D'Ippolito JA; Shei GJ; Meinz M; Onishi J; Marrinan JA; Li W; Abruzzo GK; Flattery A; Bartizal K; Mitchell A; Kurtz MB
Antimicrob Agents Chemother; 1997 Nov; 41(11):2471-9. PubMed ID: 9371352
[TBL] [Abstract][Full Text] [Related]
17. Benzylic Dehydroxylation of Echinocandin Antifungal Drugs Restores Efficacy against Resistance Conferred by Mutated Glucan Synthase.
Logviniuk D; Jaber QZ; Dobrovetsky R; Kozer N; Ksiezopolska E; Gabaldón T; Carmeli S; Fridman M
J Am Chem Soc; 2022 Apr; 144(13):5965-5975. PubMed ID: 35347986
[TBL] [Abstract][Full Text] [Related]
18. Correlating echinocandin MIC and kinetic inhibition of fks1 mutant glucan synthases for Candida albicans: implications for interpretive breakpoints.
Garcia-Effron G; Park S; Perlin DS
Antimicrob Agents Chemother; 2009 Jan; 53(1):112-22. PubMed ID: 18955538
[TBL] [Abstract][Full Text] [Related]
19. Candida albicans and Candida glabrata clinical isolates exhibiting reduced echinocandin susceptibility.
Katiyar S; Pfaller M; Edlind T
Antimicrob Agents Chemother; 2006 Aug; 50(8):2892-4. PubMed ID: 16870797
[TBL] [Abstract][Full Text] [Related]
20. Sequencing of
Arrieta-Aguirre I; Menéndez-Manjón P; Cuétara MS; Fernández de Larrinoa I; García-Ruiz JC; Moragues MD
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29229638
[No Abstract] [Full Text] [Related]
[Next] [New Search]